<DOC>
	<DOCNO>NCT00094991</DOCNO>
	<brief_summary>The purpose study learn muraglitazar lower blood sugar people type 2 diabetes . The safety treatment also study .</brief_summary>
	<brief_title>Mechanism Action Efficacy Muraglitazar Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>Type 2 diabetes ; Serum triglyceride concentration &lt; = 600 mg/dL ; Body mass index &lt; = 37 kg/m2 Type 1 diabetes ; History myocardial infarction ( MI ) , coronary angioplasty , bypass graft ( ) , valvular disease , unstable angina pectoris , transient ischemic attack ( TIA ) , cerebrovascular accident ( CVA ) within 6 month ; Congestive heart failure ( NYHA Class III IV ) ; Uncontrolled hypertension ; Women Child Bearing Potential History renal disease , peripheral vascular disease ( PVD ) , pulmonary disease , gastrointestinal disease , active liver disease , endocrine disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Type 2 diabetes</keyword>
</DOC>